Is VRTX a good investment in 2026?

Vertex Pharmaceuticals trades at a P/E ratio of 31.3, with high volatility (31.7% annualized). The stock is in a consolidation phase.

What is the risk level of VRTX?

Based on 30-day volatility of 31.7%, VRTX has HIGH risk. Beta of 0.32 indicates lower sensitivity to market movements than average.

Vertex Pharmaceuticals (VRTX) Stock Analysis & Price Target

Q: Does VRTX pay dividends?

Vertex Pharmaceuticals currently does not pay a regular dividend.

Key Metrics

MARKET CAP

$121.95B

P/E RATIO

31.3

BETA

0.32

Less volatile

DIV YIELD

N/A

52W HIGH

$519.68

52W LOW

$362.50

VOLATILITY

31.7%

30d annualized

Price Performance

30-DAY PRICE CHART

$474.17 → $480.13+1.26%

30 days agoToday

1-YEAR PERFORMANCE

$479.79 → $480.13+0.1%

VRTX | 52-week chartLast updated: 2/27/2026

Healthcare Sector Context

Defensive sector including pharmaceuticals, biotech, medical devices, and healthcare services.

METRIC	VRTX	SECTOR AVG	VS SECTOR
P/E Ratio	31.3x	22.0x	↑ 42%
Beta	0.32	0.85	Less volatile
30d Volatility	31.7%	22%	Higher risk

TOP HEALTHCARE PEERS

UNH JNJ PFE

Competitors Analysis

Compare VRTX's key metrics against its main healthcare sector competitors.

COMPANY	PRICE	MARKET CAP	SECTOR
VRTX(You are here)	$480.13	$121.95B	Healthcare	—
UNH	$286.66	$259.67B	Healthcare	VIEW →
JNJ	$243.47	$586.74B	Healthcare	VIEW →
PFE	$27.10	$154.08B	Healthcare	VIEW →

Click on a competitor to view their full analysis

Technical Analysis

Vertex Pharmaceuticals is currently trading at $480.13, which is 7.6% below its 52-week high. With a beta of 0.32, the stock shows lower sensitivity to market movements.

RSI (14)NEUTRAL

30-DAY TRENDNEUTRAL

VOLUME1.3M(Below avg)

Frequently Asked Questions

Is VRTX a good buy right now?

Vertex Pharmaceuticals trades at 31.3x earnings. This is above market average, reflecting growth expectations. Current risk level is High based on 31.7% volatility.

Does VRTX pay dividends?

Vertex Pharmaceuticals does not currently pay a regular dividend. The company may be reinvesting profits for growth.

How volatile is VRTX?

With 30-day annualized volatility of 31.7% and beta of 0.32,VRTX is classified as High risk. The stock tends to be more stable than the market average.

Related Assets

LLYANALYZE →

Eli Lilly and Company

Track VRTX Live

Add Vertex Pharmaceuticals to your Portfolio Terminal for real-time alerts and risk updates.

OPEN TERMINAL

Last updated: 2/27/2026, 2:03:37 PM